RecruitingNCT05449002
This study is looking at whether a digital support tool can help people with Anxiety, Depression, Conduct Disorder, or Stress. Participants take part in a digital support tool and complete follow-up assessments.
AnxietyOtherFrom 9 Years to 17 Years
- Countries
- United States
- Sponsor
- Harvard University
- Condition
- Anxiety
Not Yet RecruitingNCT07393919
This observational study is following people with Depression - depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherOver 18 Years
- Countries
- Global
- Sponsor
- Universita di Verona
- Condition
- Depression
UnknownNCT04792086
This study is looking at examine which impact lockdown strategies intending to prevent the spread of COVID-19 had on people with cognitive impairment and dementia for people with Dementia, Cognitive Impairment, Depression, Anxiety, or Loneliness. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionOtherOver 70 Years
- Countries
- Norway
- Sponsor
- Norwegian Centre for Ageing and Health
- Condition
- Depression
Not Yet RecruitingNCT07110831
This study is looking at whether cognitive behavioural therapy can help people with Depression or Hiv. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDrugOver 18 Years
- Countries
- Nigeria
- Sponsor
- University of Ibadan
- Condition
- Depression
RecruitingNCT05905705
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Washington University School of Medicine
- Condition
- Depression
RecruitingNCT07101796
This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionDeviceFrom 18 Years to 70 Years
- Countries
- China
- Sponsor
- Peking University First Hospital
- Condition
- Depression
RecruitingNCT05710237
This study is comparing Psilocybin 25 mg with placebo for people with Treatment-resistant Depression. Participants receive Psilocybin 25 mg or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Depression
RecruitingNCT07136714
This study is comparing Semaglutide Injectable Product with placebo for people with depression. Participants receive Semaglutide Injectable Product or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Denmark
- Sponsor
- Nordsjaellands Hospital
- Condition
- Depression
RecruitingNCT05909267
This study is looking at care and outcomes for people with major depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
- Condition
- Depression
Active Not RecruitingNCT04469959
This study is looking at whether L-Dopa can help people with depression. Participants take part in L-Dopa and complete follow-up assessments.
DepressionOtherOver 60 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Depression
RecruitingNCT06075771
This study is comparing Carbidopa Levodopa with placebo for people with Anhedonia or Depression. Participants receive Carbidopa Levodopa or placebo and complete study visits and assessments.
DepressionOtherFrom 25 Years to 55 Years
- Countries
- United States
- Sponsor
- Emory University
- Condition
- Depression
RecruitingNCT06828887
This study is recruiting in China. It is testing LV232 Capsules for Depression.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Vigonvita Life Sciences
- Condition
- Depression